• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Using injectabIe fiIIers for midface rejuvenation

    2021-05-07 06:31:32BeatriceGoArieIFrostOrenFriedman
    Plastic and Aesthetic Research 2021年7期

    Beatrice C. Go, ArieI S. Frost, Oren Friedman

    1Department of Otorhinolaryngology, Hospital of University of Pennsylvania, Pennsylvania, PA 19104, USA.

    2Division of Facial Plastic & Reconstructive Surgery, Department of Otorhinolaryngology, Hospital of University of Pennsylvania,Pennsylvania, PA 19107, USA.

    ★co-first authors.

    Abstract

    Keywords: Hyaluronic acid, midface, nasolabial fold, mouth, aging, face, fillers

    INTRODUCTION

    Treating the aging face is a popular area of medicine, as every human is subject to the physiologic process of aging. Understanding the intrinsic physiological aging process is crucial for appropriate and individualized treatment selection. The age results in thinning of the epidermis, flattening of the dermal-epidermal junction, slower wound healing, and decreased cellular proliferation[1]. Reduced synthesis of collagen due to fibroblast aging and collagen damage change the overall composition of the skin[2,3]. Extrinsic aging, most commonly attributed to sun damage but also to tobacco use and gravity, can further exacerbate the appearance of dull, discolored, and wrinkled skin. Loss of subcutaneous volume from these mechanisms is the hallmark of the aging face. In the midface, deepening of the nasolabial folds and marionette lines around the mouth are attributed to the descent of nearby fat collections[4]. Additionally, significant atrophy of the deep facial fat that provides structural volume and support to the midface occurs with aging and has a profound impact on malar projection[5-7].

    A variety of treatment options for the aging face exist, and they include both surgical and nonsurgical alternatives. Since the introduction of facelift surgery in the early twentieth century, numerous developments have allowed for more satisfactory and long-lasting aesthetic results[8-10]. The modern-day rhytidectomy involves manipulation (i.e., plication, imbrication) of the superficial musculoaponeurotic system (SMAS). The deep-plane facelift has been touted as a procedure that better improves the nasolabial fold and malar fat pad[11]. This technique involves sub-SMAS dissection with the simultaneous release of midfacial ligaments, allowing for repositioning of the malar fat pad. In exchange, however, patients are subject to greater tissue trauma, longer operative time, and increased risk of damage to the facial nerve[10].Minimally invasive and noninvasive techniques such as the threadlift[12], S-Lift[13], and minimal access cranial suspension lift[14]are all attractive options, although the longevity of results is debated. No single approach to surgical intervention has been identified as ideal - patient need, patient choice, and surgeon preference tend to guide treatment selection[15,16].

    Soft tissue fillers represent the frontline of nonsurgical alternatives for facial rejuvenation. There are a plethora of options for dermal fillers with variations in material, permanency, viscosity (G’), elasticity (G’),and longevity. The Food and Drug Administration (FDA) has approved different injectables for specific areas of the face and disease processes, although off-label use to achieve facial rejuvenation is common practice. In the midface, injectable fillers appeal to diminish the appearance of nasojugal and nasolabial grooves and augment the malar region. The efficacy and safety profile of injectable fillers is well-reported,although the “temporary” nature of these products often necessitates multiple procedures. Though fortunately rare, intravascular infiltration and vascular compression by filler are concerning events and may lead to devastating complications[17]. Other nonsurgical options reported in the literature include intradermal botulinum toxin injection[18,19], acoustic wave therapy[20], laser[21], and ultrasound[22].

    There are a variety of injectable fillers available for the treatment of the aging midface. The objective of this review is to describe the mechanism of action, indication, technique, and evidence of efficacy and safety.Understanding the advantages and limitations of injectable fillers for midface augmentation allows providers to appropriately counsel and treat patients.

    HyaIuronic acid

    The first soft-tissue fillers derived from bovine collagen in 1981 were immunogenic and caused inflammatory reactions[23]. The next generation of injectable fillers included hyaluronic acid (HA), an injectable extracellular matrix component. HA is a non-sulfated glycosaminoglycan composed of polymeric disaccharides with the unique property of forming stable structures in aqueous solutions[24]. The biological functions of HA throughout the body include lubrication of joint spaces and repair of tissue injury and wound healing[25]. In addition, dermal HA is diminished during the aging process, leading to loss of skin moisture, skin atrophy, and loss of elasticity[26]. Due to its molecular consistency across species, the minimal immunogenicity and relative ease of use have allowed HA fillers to be the most commonly used soft-tissue filler today[27].

    As a general guideline, injection of HA fillers is performed using 27- or 30-gauge needles along Hinderer’s lines: two intersecting lines from the ala to the tragus and lateral canthus to lateral oral commissure[28][Figure 1]. The filler is then ideally placed in the upper outer quadrant. Volume replacement targeting specific midface areas is dependent on location and requires meticulous attention to ethnic differences in bony anatomy[29]. The upper cheek, lateral cheek, anterior cheek, and medial cheek are all potential injection sites, and injectors must take precautions to avoid the zygomatic neurovascular bundle, infraorbital artery and vein, and angular artery and vein[30]. Volume replacement in the lid-cheek junction (“tear trough”) can be achieved with two or three injections along the nasojugal fold though care must be taken to avoid injury to vessels and orbital content[31]. There are two strategies to approach the submalar area: subcutaneous injection at numerous sites per side or a single medial subcutaneous injection using a fanning technique[32].Providers should take care to avoid the facial vessels and parotid duct during both techniques. Volume replacement in the preauricular area can be accomplished with three to five superficial injection sites with care to avoid the parotid gland and transverse facial artery and vein[33].

    Figure 1. Hinderer’s lines (two intersecting lines: ala/tragal, lateral canthal/commissure).

    The first HA-based filler approved for use by the United States FDA was Restylane (Galderma, Fort Worth,TX) in 2003[34,35]. There are now many other products that differ in concentration, elastic modulus, and degree of cross-linking, including Juvederm (Allergan Inc., Pringy, France), which has been approved for a variety of indications, including correction of facial wrinkles and folds as well as lip and cheek augmentation. Additional modifications on these products, including a new product with increased crosslinking (Teosyal resilient HA, Geneva, Switzerland), have been created to help reduce degradation due to mechanical strain[36]. Multiple randomized controlled trials have demonstrated the efficacy of HA for agerelated midface volume deficit. In a multicenter, single-blinded, controlled study, 85.6% of subjects treated with Juvederm Voluma demonstrated a significant improvement of 1 point or more at 6 months follow-up on the Mid-Face Volume Deficit Scale, a validated blinded clinician score, compared with the control group[37]. There were minimal adverse events, and more than half of the subjects reported lasting efficacy at 24 months. A follow-up study on patient satisfaction showed that nearly 93% and 79% of patients at 6 months and 2 years after treatment, respectively, noted improvement on the Global Aesthetic Improvement Scale[38]. In addition, patients reported looking 5 years younger at 6 months and 3 years younger at 2 years.Newer split-face trials are now comparing Cohesive Polydensified Matrix (CPM) (Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) with FDA-approved Vycross technology (Allergan Inc., Pringy,France), noting noninferior aesthetic results and more favorable safety and patient satisfaction profiles with CPM[39,40].

    CaIcium hydroxyIapatite

    Calcium hydroxylapatite (CaHa) is a unique compound with dual functionality as a replacement volumizer as well as a collagen biostimulator[41]. Due to its identical composition to human bone and teeth, CaHa is biodegradable, naturally resorbable, nontoxic, nonantigenic, and long-lasting, allowing for optimal biocompatibility and efficacy as a filler material[42]. CaHa’s biostimulatory effects work by immediately creating volume while encouraging a fibroblastic response and acting as a scaffold for newly formed collagen after natural resorption and excretion[43-45]. CaHa has a wide range of indications beyond aesthetics,including correction of orthopedic[46]and dental defects[47]and vocal fold augmentation[48]. In 2006, Radiesse(Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) was FDA-approved for the correction of moderate to severe midface wrinkles and folds and lipoatrophy in patients with human immunodeficiency virus. Radiesse utilizes a 30:70 ratio mixture of CaHa microspheres to aqueous carrier gel and has been well studied in facial aesthetic medicine[42,49,50].In the midface, restoration of the cheekbones allows for correction of specific creases and defects while providing volume to the malar and submalar regions. By augmenting the upper maxillary region, the shadowing effect seen with midface defects is ameliorated, resulting in a younger appearance[51]. CaHa can be placed using a similar technique to HA, though a larger bore needle or cannula is recommended due to the relative viscosity[52]. To achieve optimal aesthetic results, augmentation of the entire cheek and adjacent areas should be considered, not just the area of the defect[49]. Injection depth depends on location; superior to the alar-tragal line, CaHa should be injected superior to the periosteum, while subdermal injections are ideal for targeting areas inferior to the alar-tragal line[53]. After product placement, light massaging and molding of the filler are recommended to blend the injectable and reduce tissue edema and ecchymosis,thereby helping to achieve the desired outcome[42].

    There is a plethora of data supporting the long-term safety and efficacy of CaHa for facial soft-tissue augmentation. The first pivotal multi-center study comparing CaHa against human collagen in a randomized split-face trial reported significantly longer-lasting correction of nasolabial folds with less material used and fewer injections[54]. A follow-up safety study of 113 patients over 47 months showed only seven minor adverse events, including transient ecchymosis, submucosal nodules, and inflammation and edema[55]. Duration of action ranges from 12 to 18 months though long-term effectiveness of up to 30 months has been reported[56]. Despite these promising results, one systematic review reported that Radiesse was significantly more likely to result in intra-arterial complications and skin necrosis when compared with other facial fillers[57]. It is thought that the larger particle size of Radiesse increases the propensity of vascular compromise. Thus, the provider must remain vigilant to avoid vascular complications.

    PoIy-L-Iactic acid

    Poly-L-lactic acid (PLLA) is an absorbable, semi-permanent, biocompatible synthetic polymer that induces collagen synthesis, leading to volume restoration. After injection, PLLA particles stimulate an inflammatory response with tissue macrophages, leading to degradation into lactic acid and subsequently carbon dioxide and water[58]. This process promotes the formation of new type-I collagen as well as fibroblast activity,leading to gradual volume replacement[59]. The effect of PLLA stems from the natural host response rather than the immediate volume increase, thus leading to an extended duration of action from 12 to 24 months[60].

    In the United States, Sculptra (Galderma, Fort Worth, TX) has been FDA-approved for facial lipoatrophy associated with HIV and more recently in 2009 for the correction of shallow to deep nasolabial folds and other facial wrinkles[17]. The product must be reconstituted with Sterile Water for Injection (5 mL) prior to injection to form a sterile suspension[61]. When approaching the midface, supraperiosteal injections over the zygoma, maxilla, and temples and subcutaneous injections in the submalar and preauricular areas are recommended[62]. Consensus guidelines recommend 3-5 initial sessions for optimal results, with at least four weeks between sessions. Patients should be counseled that cosmetic effects have a gradual onset and can last two years or more[62]. Due to the slowly progressive bulking effects of PLLA, it is important to not overcorrect the treatment area with too much filler[63].

    Multiple retrospectives and prospective cohort studies have demonstrated the safety of injectable PLLA[64-67].For example, a pivotal randomized, single-blinded, multicenter trial in 2010 compared the efficacy and safety of PLLA with human-derived collagen for nasolabial fold deficits[68]. Subjects receiving injectable PLLA had significantly improved average Wrinkle Assessment Scale scores at all-time points up to 25 months compared with the control group. Other similar trials have reported high provider and patient satisfaction with results[69,70]. Compared to HA fillers, PLLA was found to be noninferior in the correction of moderate to severe nasolabial folds and appeared to be superior to HA in patients less than 52 years of age[71]. Main adverse effects include papules and nodules stemming from unequal distribution, inaccurate placement, and incorrect reconstitution[72]. As preparation and administration of PLLA have become increasingly standardized, however, the frequency of post-injection complications has also decreased[73].

    PoIymethyI methacryIate

    Polymethyl methacrylate (PMMA) is a synthetic, biologically compatible, inert, nonbiodegradable polymer originally used in dental and orthopedic procedures. Although a previous version (Artecoll, Canderm Pharma Inc, Canada) was marketed outside of the United States, newer generations of PMMA injectable fillers (ArteFill, later rebranded as Bellafill, Suneva Medical, San Diego, CA, USA) have been FDA approved for nasolabial fold augmentation since 2006[17,74]. These formulations contain PMMA microspheres, which are evenly distributed among denatured bovine collagen and lidocaine. Compared to other injectable filler materials, PMMA is a small, smooth permanent filler without electrical charge, thus preventing phagocytosis and degradation by macrophages[75]. Initial volume restoration is attributed to the collagen content in the filler though after this component is resorbed after 1 to 3 months, PMMA microspheres become permanently encapsulated with connective tissue and cells[76]. Due to the bovine collagen suspension, skin allergy testing must be conducted 2-4 weeks prior to injection, and double skin testing is often recommended to reduce the severity and incidence of allergic reactions[77]. On account of its permanent nature, the administration of PMMA requires careful attention to detail and placement. PMMA should be implanted intradermally, just superior to the dermis and subcutaneous layer[78]. The tunneling technique, or moving the needle back and forth beneath a wrinkle, allows for even distribution and layering of the product.

    PMMA was initially introduced worldwide in the 1990s and became approved in 2006 after a multicenter randomized controlled trial of 251 subjects receiving Artecoll for a variety of facial wrinkles reported superior results to collagen dermal filler[78]. At 6 months follow-up, investigator and subject satisfaction ratings were higher at all injection sites, and significant augmentation was present at 12 months follow-up.After Artecoll, the next generation of PMMA was named Artefill, which boasted greater uniformity in size,surface contour, smoothness, and roundness[79]. Since then, PMMA has been repackaged as Bellafill, which offers a very favorable risk/benefit profile when administered properly. Short-term complications (tissue necrosis, infection) and long-term sequelae (granulomas, chronic inflammatory reaction) have been reported though they are fortunately rare occurrences[80]. A total of 1008 subjects receiving PMMA fillers for nasolabial folds was followed over five years, with biopsy-confirmed granulomas occurring in 1.7%[81].Almost all granulomas resolved with intralesional corticosteroid injections, and overall satisfaction rates remained high through the study period. In the event of nodules, skin changes, or contour irregularity,another study reported that surgical debulking of material could reduce the effects of these complications[82]. Long-term data also supports an excellent safety profile for this filler type. Surveillance data from 2007 to 2016 for more than half a million Bellafill syringes showed 11 total confirmed granulomas(0.002% or syringes sold)[79].

    FiIIers vs. surgery

    Although deep dermal fillers offer safe and excellent cosmetic results, it is important to consider which patients would likely benefit more from surgery. For those with more significant midface ptosis and facial volume loss, the more permanent and dramatic effects of rhytidectomy are more appealing. The main goals of the midface lift include effacement of the lower lid-cheek junction with volume restoration of the cheek and malar eminence[83]. Although a thorough discussion of surgical techniques is out of the scope of this review, providers must evaluate which patients would benefit from fillers, surgery, or a combination of both.During this conversation, differences in expected outcomes and recovery for the treatment options should be covered. If patients are willing to undergo general anesthesia and have significant soft tissue ptosis, most experts agree that a midface lift may be the more appropriate solution[83]. The addition of soft tissue fillers should be a separate discussion after the patient has had ample time to recover, allowing for the settling of the soft tissue.

    Midface surgical options can confer longer-lasting results when compared with midface fillers. In a series of 157 patients undergoing a primary facelift at age < 50, patients reported appearing significantly younger after facelift compared with after nonsurgical intervention (8 yearsvs.4 years,P= 0.048)[84]. Thirty-two percent of patients underwent an average of 7 rounds of injectable fillers prior to surgical intervention, with an average expenditure of $7000 on nonsurgical procedures. Longevity of midface lift approaches has been reported, although most outcome measures are largely subjective, citing high patient satisfaction and quality of life scores at up to 5 years follow-up[85,86]. A recent study described a series of 143 patients undergoing an endoscopic transtemporal approach, reporting a significant, objective improvement in midfacial height that persisted for up to 15 years[87]. Despite these encouraging and lasting aesthetic results, no procedure is without its risks, which must be extensively discussed when counseling patients. The complications of midface lift surgery include asymmetry, infection, hematoma, facial and trigeminal neuropathy, and undesired scarring[88].

    DISCUSSION

    Management of the midface with volume augmentation can be safely and effectively achieved with the use of soft tissue injectable fillers. The selection of filler is largely dependent on patient factors, including the severity of ptosis, degree of volume loss, age, cost, preference, and surgical candidacy[88]. From the provider’s perspective, a detailed understanding of anatomy in the nasal region as well as proper technique is fundamental to minimizing the risk of complications and achieving the desired effect.

    For decades, surgical rhytidectomy was established as the frontline procedure to enable patients to achieve predictable, customizable, and natural-looking results. However, the popularity of minimally invasive techniques has increased rapidly due to the introduction and wide acceptance of soft tissue fillers. Among the younger patient population that is not quite ready for a facelift, injectable fillers are an attractive, less permanent alternative to surgery. Compared to undergoing more invasive surgery, fillers offer the patient less discomfort and a shorter recovery time, making them very practical. Additionally, new and innovative advances to avoid anatomic danger zones and improve overall technique have led to safer injection practices[89-91]. Needle aspiration prior to injecting the filler has been reported to help prevent accidental intravascular injection[92]. With appropriate handling and adequate experience, injectable fillers are a safe and effective option for the aging midface.

    The increasing popularity of facial fillers is well reflected in popular media and online news coverage. For example, a Google News search for articles on “facial fillers” from 2008 to 2017 reported coverage as 45%positive, 30% neutral, and 25% negative[93]. While most media coverage at national and international levels was fairly positive, there was some concern with the regulation of facial fillers, a salient issue that may incite apprehension in some patients interested in the procedure. Additionally, nearly half of the papers discussed complications associated with the procedure despite the overall rarity of vascular injury and blindness[94,95].As most cases of vision loss do not recover, and there is no consistent treatment for blindness, it is crucial for providers to understand the risks involved with the procedure and appropriately counsel patients[96].

    From an economic standpoint, the short-term cost of injectable fillers is another advantage for patients seeking minimally invasive treatment. However, a study by Biskupiak and Sclafani among several facial plastic surgeries and dermatology practices in New York City estimated that the total medical cost for surgical rhytidectomy was around $10,181[97]. When comparing this value to large-volume facial soft tissues assuming 90 months of the desired effect, the medical cost for surgery was the lowest cost option among the other treatments. When considering total costs, including workdays lost, ArteFill ($11,151 for 1 treatment)and Sculptra ($14,850 for 3.75 treatments) were less costly than surgical rhytidectomy ($15,181). This discrepancy was attributed to extra fees due to anesthesia, operating room, and overhead hospital costs, as well as the lengthier recovery period for surgery. However, it is important to consider that a rhytidectomy may ultimately be more cost-effective compared to patients undergoing large-volume filler augmentation over the course of several years.

    There are multiple advances in filler technology to increase longevity while improving efficacy and safety profiles. For example, a new line of dermal fillers, called resilient hyaluronic acid (RHA) (Revance Therapeutics, Nashville, TN), was designed with a cross-linking method to mimic the function of native HA better. It is thought that these products (RHA 2, 3, 4) are able to adapt to facial movements to treat dynamic wrinkles and folds, a typical indication for neuromodulators[98]. Recently FDA approved for the correction of deep dynamic wrinkles, including the nasolabial folds; RHA 2 and 3 are indicated for injection into the mid-to-deep dermis, while RHA 4 is indicated for injection into the deep dermis to superficial subcutaneous tissue[99]. One split-face, randomized controlled trial on 90 subjects with moderate to severe nasolabial folds found at least equivalent efficacy and safety profiles with comparable fillers[100]. However, immediate and long-term satisfaction for both investigators and subjects favored RHA fillers with no reports of serious adverse events. At this time of writing, other dermal fillers expected to come to the United States market include Juvederm Volite (Allergan, Dublin, Ireland), the HA-based filler meant to improve skin quality, and ProfHilo (IBSA Nordic ApS, Denmark), another HA-based filler without any chemical cross-linking agents[101,102].

    CONCLUSION

    As a result of volume loss and fat atrophy, the aging midface is characterized by overall drooping of soft tissues and deepening of the nasolabial folds. Although surgical rhytidectomy is a long-lasting option for these patients, recent nonsurgical avenues, including filler injections, are becoming more popular due to reduced patient discomfort and recovery times. While filler selection may depend on patient preference and individual goals, providers must remain informed on the potential complications associated with midface augmentation and provide appropriate preprocedural counseling.

    DECLARATIONS

    Authors’ contributions

    Made substantial contributions to conception and design of the study, performed interpretation of data for the work, drafted the work, gave final approval of the version to be published, agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: Go BC, Frost AS

    Made substantial contributions to conception and design of the study, revised it critically for important intellectual content, gave final approval of the version to be published, agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: Friedman O

    AvaiIabiIity of data and materiaIs

    Not applicable.

    FinanciaI support and sponsorship

    None.

    ConfIicts of interest

    All authors declared that there are no conflicts of interest.

    EthicaI approvaI and consent to participate

    Not applicable.

    Consent for pubIication

    Not applicable.

    Copyright

    ? The Author(s) 2021.

    亚洲三级黄色毛片| av免费观看日本| 婷婷六月久久综合丁香| 亚洲伊人久久精品综合 | 亚洲精品日韩av片在线观看| 看片在线看免费视频| 中文字幕亚洲精品专区| 国产精品国产三级国产专区5o | 国产熟女欧美一区二区| 成人高潮视频无遮挡免费网站| 国产白丝娇喘喷水9色精品| 白带黄色成豆腐渣| 国产免费福利视频在线观看| 久久99蜜桃精品久久| 村上凉子中文字幕在线| 五月伊人婷婷丁香| 男人舔女人下体高潮全视频| 五月伊人婷婷丁香| 久久精品夜夜夜夜夜久久蜜豆| 亚洲国产精品sss在线观看| 日本午夜av视频| 免费av毛片视频| 国产黄a三级三级三级人| 国产亚洲最大av| 99久久无色码亚洲精品果冻| 在现免费观看毛片| 久久久久性生活片| 久久精品国产亚洲网站| 久热久热在线精品观看| 国产精品永久免费网站| 99久久精品一区二区三区| 国产毛片a区久久久久| 亚洲av二区三区四区| 亚洲电影在线观看av| 纵有疾风起免费观看全集完整版 | 成人午夜精彩视频在线观看| 免费av观看视频| 少妇高潮的动态图| 久久久亚洲精品成人影院| 亚洲av成人精品一二三区| 久久精品夜夜夜夜夜久久蜜豆| 亚洲综合色惰| 久久人人爽人人爽人人片va| 噜噜噜噜噜久久久久久91| 淫秽高清视频在线观看| 成人国产麻豆网| 国产三级在线视频| 两个人的视频大全免费| 汤姆久久久久久久影院中文字幕 | 久久热精品热| 日韩精品有码人妻一区| 波多野结衣高清无吗| 久久久午夜欧美精品| 在线观看一区二区三区| 国产精品国产三级国产av玫瑰| 男女国产视频网站| 在线免费十八禁| 免费人成在线观看视频色| 国内精品美女久久久久久| 日韩大片免费观看网站 | 精品欧美国产一区二区三| 老女人水多毛片| 中文亚洲av片在线观看爽| 日韩大片免费观看网站 | 在线观看66精品国产| 成人国产麻豆网| 精品久久久久久久末码| 日韩视频在线欧美| 欧美又色又爽又黄视频| 久久精品久久精品一区二区三区| 天堂影院成人在线观看| 久久热精品热| 嫩草影院新地址| 久久久国产成人精品二区| 伦精品一区二区三区| 91aial.com中文字幕在线观看| 淫秽高清视频在线观看| 欧美另类亚洲清纯唯美| 国产免费福利视频在线观看| 国产精品爽爽va在线观看网站| 午夜激情福利司机影院| 看免费成人av毛片| 亚洲精品色激情综合| 老司机影院成人| 国产精品电影一区二区三区| 村上凉子中文字幕在线| 欧美成人一区二区免费高清观看| 免费人成在线观看视频色| 国产爱豆传媒在线观看| 日韩成人av中文字幕在线观看| 亚洲欧美精品综合久久99| 观看免费一级毛片| 久久精品国产鲁丝片午夜精品| 欧美极品一区二区三区四区| 欧美丝袜亚洲另类| videossex国产| 少妇的逼好多水| 久久久精品94久久精品| av在线播放精品| 国产真实乱freesex| 亚洲美女搞黄在线观看| 国产精品人妻久久久久久| 国产精品一区二区在线观看99 | 国产一区二区三区av在线| 久久久午夜欧美精品| 久久精品国产99精品国产亚洲性色| 欧美成人精品欧美一级黄| 国产色爽女视频免费观看| 国产午夜精品论理片| av.在线天堂| 欧美bdsm另类| 青春草亚洲视频在线观看| 美女cb高潮喷水在线观看| 国产综合懂色| 亚洲真实伦在线观看| 最近视频中文字幕2019在线8| 1024手机看黄色片| 国产乱来视频区| 听说在线观看完整版免费高清| 午夜激情欧美在线| 可以在线观看毛片的网站| 寂寞人妻少妇视频99o| 爱豆传媒免费全集在线观看| 午夜福利在线观看吧| 美女cb高潮喷水在线观看| 国产精品一二三区在线看| 一卡2卡三卡四卡精品乱码亚洲| 小蜜桃在线观看免费完整版高清| 欧美日韩综合久久久久久| 免费观看a级毛片全部| 乱人视频在线观看| 日本欧美国产在线视频| 中国美白少妇内射xxxbb| av国产免费在线观看| 丝袜美腿在线中文| 欧美潮喷喷水| 日本wwww免费看| 精品欧美国产一区二区三| 久久久久久久久中文| 日本色播在线视频| 在现免费观看毛片| 麻豆成人av视频| 男人舔女人下体高潮全视频| 最后的刺客免费高清国语| 亚洲三级黄色毛片| 精品久久久久久久久亚洲| 性色avwww在线观看| 免费人成在线观看视频色| 久久99精品国语久久久| 日韩欧美精品免费久久| 国产精品不卡视频一区二区| 色噜噜av男人的天堂激情| 久久久久九九精品影院| 亚洲成av人片在线播放无| www日本黄色视频网| 一级毛片我不卡| 国产伦精品一区二区三区四那| 欧美日韩在线观看h| 99久久无色码亚洲精品果冻| 国产色婷婷99| 黄片wwwwww| 日韩高清综合在线| 99久久精品一区二区三区| 深夜a级毛片| 最后的刺客免费高清国语| 国产伦精品一区二区三区四那| 久久国产乱子免费精品| 久久久久网色| 欧美不卡视频在线免费观看| 97在线视频观看| 嘟嘟电影网在线观看| 欧美区成人在线视频| 国产精品日韩av在线免费观看| 成人二区视频| 中文亚洲av片在线观看爽| 中文字幕熟女人妻在线| 直男gayav资源| 亚洲精品aⅴ在线观看| 精品免费久久久久久久清纯| 99久久精品一区二区三区| 少妇被粗大猛烈的视频| 成人av在线播放网站| 欧美潮喷喷水| av天堂中文字幕网| 久久久国产成人精品二区| 三级毛片av免费| 久久精品夜色国产| 精品久久久久久久久久久久久| h日本视频在线播放| av播播在线观看一区| 国国产精品蜜臀av免费| 亚洲欧美一区二区三区国产| 国产在线男女| 日产精品乱码卡一卡2卡三| 国产精品女同一区二区软件| 美女高潮的动态| 麻豆av噜噜一区二区三区| 免费一级毛片在线播放高清视频| 永久免费av网站大全| 七月丁香在线播放| 国模一区二区三区四区视频| 亚洲av电影不卡..在线观看| 国产又色又爽无遮挡免| 91av网一区二区| 天美传媒精品一区二区| 亚洲国产成人一精品久久久| 亚洲国产精品合色在线| 久久精品久久久久久噜噜老黄 | 卡戴珊不雅视频在线播放| 午夜福利成人在线免费观看| 成人高潮视频无遮挡免费网站| 日韩精品有码人妻一区| 亚洲va在线va天堂va国产| 中文字幕久久专区| 国产精品乱码一区二三区的特点| 国产精品福利在线免费观看| 国产视频首页在线观看| 亚洲欧美中文字幕日韩二区| 精品久久久噜噜| 1000部很黄的大片| 97超视频在线观看视频| 亚洲av电影不卡..在线观看| 国产三级中文精品| 国产精品熟女久久久久浪| 国产成人freesex在线| 又粗又硬又长又爽又黄的视频| 晚上一个人看的免费电影| 一区二区三区高清视频在线| 午夜老司机福利剧场| 97超碰精品成人国产| 美女黄网站色视频| 亚洲精品456在线播放app| 两个人的视频大全免费| 春色校园在线视频观看| 伦理电影大哥的女人| 综合色av麻豆| 黄色欧美视频在线观看| 国产私拍福利视频在线观看| 内地一区二区视频在线| 亚洲成人中文字幕在线播放| 久久99热6这里只有精品| 亚洲第一区二区三区不卡| 日本av手机在线免费观看| 国产色婷婷99| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 最近视频中文字幕2019在线8| 国产大屁股一区二区在线视频| 欧美日本亚洲视频在线播放| 人妻少妇偷人精品九色| 欧美日韩综合久久久久久| 免费观看人在逋| 精品国内亚洲2022精品成人| 日韩大片免费观看网站 | 婷婷色麻豆天堂久久 | 亚洲av中文av极速乱| 一级毛片我不卡| 两性午夜刺激爽爽歪歪视频在线观看| 最近视频中文字幕2019在线8| 久久久久久久亚洲中文字幕| 免费av毛片视频| 亚洲精品456在线播放app| 国产爱豆传媒在线观看| 午夜精品在线福利| 熟女电影av网| 99国产精品一区二区蜜桃av| 日日摸夜夜添夜夜添av毛片| 国产男人的电影天堂91| 国产精品永久免费网站| 亚洲av成人精品一二三区| 桃色一区二区三区在线观看| 神马国产精品三级电影在线观看| 精品一区二区三区视频在线| 国产免费福利视频在线观看| 免费观看的影片在线观看| 看免费成人av毛片| 日本爱情动作片www.在线观看| 99久久精品一区二区三区| 亚洲av.av天堂| 18禁动态无遮挡网站| 男人舔奶头视频| 精品欧美国产一区二区三| 国产精品1区2区在线观看.| 综合色av麻豆| 亚洲av不卡在线观看| 在线观看66精品国产| 高清日韩中文字幕在线| 国产亚洲av嫩草精品影院| 波多野结衣巨乳人妻| 久久国产乱子免费精品| 亚洲高清免费不卡视频| 亚洲在线观看片| 国产三级中文精品| 六月丁香七月| 天堂av国产一区二区熟女人妻| 日韩一本色道免费dvd| 乱人视频在线观看| 精品久久久久久久久久久久久| 国内少妇人妻偷人精品xxx网站| 免费不卡的大黄色大毛片视频在线观看 | 国产精品永久免费网站| 色网站视频免费| 黑人高潮一二区| 国产精品久久久久久精品电影小说 | 一级黄片播放器| 国产欧美日韩精品一区二区| 日韩av在线免费看完整版不卡| 亚洲国产精品成人综合色| 亚洲av电影不卡..在线观看| 纵有疾风起免费观看全集完整版 | av国产免费在线观看| 久久久久网色| 久久久久久久久中文| 日本午夜av视频| 久久久久网色| 两性午夜刺激爽爽歪歪视频在线观看| 亚洲美女视频黄频| 男女视频在线观看网站免费| 亚洲av电影不卡..在线观看| 精品国产一区二区三区久久久樱花 | 身体一侧抽搐| a级毛片免费高清观看在线播放| 国产人妻一区二区三区在| 一个人看视频在线观看www免费| 免费观看a级毛片全部| 永久网站在线| 国产亚洲最大av| 水蜜桃什么品种好| 日韩国内少妇激情av| 国产亚洲午夜精品一区二区久久 | 欧美精品国产亚洲| 国产v大片淫在线免费观看| 身体一侧抽搐| 69人妻影院| 久久久久久久亚洲中文字幕| 少妇被粗大猛烈的视频| 国产精品久久久久久精品电影小说 | a级一级毛片免费在线观看| 国产不卡一卡二| 久99久视频精品免费| 大香蕉久久网| 亚洲av成人av| 国产精品蜜桃在线观看| 精品一区二区三区人妻视频| 精品免费久久久久久久清纯| 国产探花在线观看一区二区| 国产不卡一卡二| 成人性生交大片免费视频hd| 日韩,欧美,国产一区二区三区 | 青春草视频在线免费观看| 亚洲精品成人久久久久久| 国产精华一区二区三区| 尾随美女入室| 成年女人永久免费观看视频| 久久精品国产亚洲av天美| 欧美又色又爽又黄视频| 99久久无色码亚洲精品果冻| 中国美白少妇内射xxxbb| 99久久中文字幕三级久久日本| 亚洲国产最新在线播放| 亚洲在久久综合| 男女边吃奶边做爰视频| 韩国高清视频一区二区三区| 成人亚洲欧美一区二区av| 久久亚洲精品不卡| 性色avwww在线观看| 色5月婷婷丁香| 男女下面进入的视频免费午夜| 最后的刺客免费高清国语| 欧美日本视频| 久久婷婷人人爽人人干人人爱| 国产精品熟女久久久久浪| 久久久久久久久中文| 丰满人妻一区二区三区视频av| 午夜精品国产一区二区电影 | 男人的好看免费观看在线视频| 国产精品乱码一区二三区的特点| 国产成人福利小说| 中文字幕亚洲精品专区| 日本黄色视频三级网站网址| 久久99热这里只频精品6学生 | 国产白丝娇喘喷水9色精品| 欧美精品国产亚洲| 内地一区二区视频在线| av在线蜜桃| 亚洲高清免费不卡视频| 国产成人一区二区在线| 久久这里只有精品中国| 人妻少妇偷人精品九色| 内射极品少妇av片p| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 欧美潮喷喷水| 深夜a级毛片| 老司机影院成人| 免费无遮挡裸体视频| 亚洲自偷自拍三级| 亚洲国产成人一精品久久久| 色网站视频免费| 日韩成人av中文字幕在线观看| 亚洲成av人片在线播放无| 免费电影在线观看免费观看| 久久99热6这里只有精品| 国产精品久久久久久久电影| 免费观看人在逋| 赤兔流量卡办理| 免费电影在线观看免费观看| 婷婷色av中文字幕| 国产免费福利视频在线观看| 丝袜美腿在线中文| 国产激情偷乱视频一区二区| 久久精品夜夜夜夜夜久久蜜豆| 国产片特级美女逼逼视频| 国产精品国产高清国产av| 日本爱情动作片www.在线观看| 啦啦啦韩国在线观看视频| 日韩欧美精品v在线| 免费搜索国产男女视频| av在线亚洲专区| 亚洲av成人av| 99久久人妻综合| 一区二区三区高清视频在线| 色播亚洲综合网| 亚洲欧美日韩东京热| 亚洲欧洲日产国产| 天堂影院成人在线观看| 亚洲精品日韩av片在线观看| 中文乱码字字幕精品一区二区三区 | 美女高潮的动态| 永久免费av网站大全| 毛片一级片免费看久久久久| 91精品一卡2卡3卡4卡| 又粗又硬又长又爽又黄的视频| av黄色大香蕉| 中文欧美无线码| 99久国产av精品国产电影| 久久鲁丝午夜福利片| 亚洲精品国产成人久久av| 亚洲精品一区蜜桃| 欧美日韩在线观看h| 秋霞在线观看毛片| 久久久久久九九精品二区国产| 欧美成人一区二区免费高清观看| 欧美潮喷喷水| 亚洲av男天堂| av黄色大香蕉| 精品久久久久久电影网 | 国产三级中文精品| av女优亚洲男人天堂| 看十八女毛片水多多多| 麻豆国产97在线/欧美| 级片在线观看| 精华霜和精华液先用哪个| 欧美一区二区国产精品久久精品| 18禁动态无遮挡网站| 22中文网久久字幕| 毛片一级片免费看久久久久| 伦精品一区二区三区| 久久人人爽人人爽人人片va| 亚洲精品乱码久久久v下载方式| 少妇丰满av| 最近中文字幕高清免费大全6| 久久久久久久久久成人| 一个人观看的视频www高清免费观看| 你懂的网址亚洲精品在线观看 | 国产一区二区三区av在线| 别揉我奶头 嗯啊视频| 国产精品人妻久久久影院| 国产午夜精品一二区理论片| 国产高清有码在线观看视频| 欧美日韩一区二区视频在线观看视频在线 | 亚洲精品久久久久久婷婷小说 | 人人妻人人澡欧美一区二区| 日本三级黄在线观看| 精品午夜福利在线看| 亚洲成av人片在线播放无| 91久久精品国产一区二区成人| av.在线天堂| 国产中年淑女户外野战色| 日本午夜av视频| 久久人妻av系列| 成人特级av手机在线观看| 少妇熟女aⅴ在线视频| 国语对白做爰xxxⅹ性视频网站| 日韩欧美 国产精品| 国产69精品久久久久777片| 国产精品av视频在线免费观看| 成人综合一区亚洲| 深爱激情五月婷婷| 一级黄色大片毛片| 狂野欧美白嫩少妇大欣赏| 成人三级黄色视频| 国产色爽女视频免费观看| or卡值多少钱| av福利片在线观看| 久久精品夜色国产| 热99在线观看视频| 啦啦啦韩国在线观看视频| 免费观看人在逋| 精品国产露脸久久av麻豆 | 内地一区二区视频在线| 国产黄a三级三级三级人| 国产探花极品一区二区| 禁无遮挡网站| 亚洲真实伦在线观看| 别揉我奶头 嗯啊视频| 高清av免费在线| 国产精品乱码一区二三区的特点| 男人和女人高潮做爰伦理| 久久99蜜桃精品久久| 国产乱来视频区| 日产精品乱码卡一卡2卡三| 2022亚洲国产成人精品| 丝袜美腿在线中文| 日日摸夜夜添夜夜添av毛片| 亚洲国产欧美人成| 亚洲丝袜综合中文字幕| 长腿黑丝高跟| 天堂网av新在线| av又黄又爽大尺度在线免费看 | 尾随美女入室| 亚洲熟妇中文字幕五十中出| 乱码一卡2卡4卡精品| 午夜福利在线在线| 亚洲国产色片| 1000部很黄的大片| 久久久久网色| 欧美精品一区二区大全| 午夜老司机福利剧场| 国产av码专区亚洲av| 男人的好看免费观看在线视频| 亚洲精品,欧美精品| 精品久久久久久久久久久久久| 亚洲精品国产成人久久av| 免费av不卡在线播放| 非洲黑人性xxxx精品又粗又长| 精品久久久久久电影网 | 日韩av在线大香蕉| 天天躁夜夜躁狠狠久久av| 国产91av在线免费观看| 国产精品日韩av在线免费观看| 国产毛片a区久久久久| 国产精品一区www在线观看| 最新中文字幕久久久久| 秋霞伦理黄片| 午夜福利在线观看吧| 日日啪夜夜撸| 真实男女啪啪啪动态图| 天美传媒精品一区二区| 纵有疾风起免费观看全集完整版 | 成人一区二区视频在线观看| 日韩av在线大香蕉| 亚洲精品自拍成人| 国产又黄又爽又无遮挡在线| 观看美女的网站| 我的老师免费观看完整版| 亚洲av电影不卡..在线观看| 久久久精品94久久精品| 99视频精品全部免费 在线| 成年免费大片在线观看| 国产成年人精品一区二区| 高清视频免费观看一区二区 | 欧美潮喷喷水| 亚洲婷婷狠狠爱综合网| 汤姆久久久久久久影院中文字幕 | 色5月婷婷丁香| 国内精品宾馆在线| 色噜噜av男人的天堂激情| 国产伦精品一区二区三区四那| 18禁在线无遮挡免费观看视频| 日日啪夜夜撸| 国产成人a区在线观看| 国产高清有码在线观看视频| 日韩一本色道免费dvd| 亚洲精品一区蜜桃| 久久精品综合一区二区三区| 少妇熟女aⅴ在线视频| 在现免费观看毛片| 成人三级黄色视频| 国产成人精品一,二区| 亚洲av一区综合| 亚洲中文字幕日韩| 青春草国产在线视频| 久久久久久久久大av| 亚洲精华国产精华液的使用体验| 午夜福利在线观看吧| 男人舔奶头视频| 直男gayav资源| 亚洲精品国产成人久久av| 亚洲av二区三区四区| 99热全是精品| 日日撸夜夜添| 亚洲无线观看免费| 一级毛片我不卡| 日本五十路高清| 国产亚洲av片在线观看秒播厂 | 爱豆传媒免费全集在线观看| 国产成人一区二区在线| 免费观看的影片在线观看| 欧美日韩在线观看h| 99热这里只有是精品50| 在线观看美女被高潮喷水网站| 精品熟女少妇av免费看| 亚洲一区高清亚洲精品| 最近最新中文字幕免费大全7| 波多野结衣巨乳人妻| 午夜福利在线观看吧| 亚洲乱码一区二区免费版| 日本一本二区三区精品| 舔av片在线| 小说图片视频综合网站| 国产精品国产三级国产专区5o | 精品国内亚洲2022精品成人| 亚洲欧美日韩卡通动漫| 久久热精品热| 国产在线一区二区三区精 | 内地一区二区视频在线|